AccuMed claims sale to unnamed HMO (Health Management Organisation):
This article was originally published in Clinica
AccuMed International says that a large, not-for-profit Health Management Organisation (HMO) in the US, serving several million members, has chosen its AcCell Cytopathology System. The system will be evaluated in one site in connection with general and cervical pathology screening programmes. Neither the name of the HMO, nor the value of the transaction, was revealed.